HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.

Abstract
Over 30 mutations of the B-RAF gene associated with human cancers have been identified, the majority of which are located within the kinase domain. Here we show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo. Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells. The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by association with the P loop. The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation. The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.
AuthorsPaul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford, Richard Marais, Cancer Genome Project
JournalCell (Cell) Vol. 116 Issue 6 Pg. 855-67 (Mar 19 2004) ISSN: 0092-8674 [Print] United States
PMID15035987 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Phosphotransferases
  • Braf protein, mouse
  • Proto-Oncogene Proteins B-raf
  • Proto-Oncogene Proteins c-raf
  • Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 1
  • MAP2K1 protein, human
  • Map2k1 protein, mouse
  • Mitogen-Activated Protein Kinase Kinases
Topics
  • Allosteric Regulation (genetics)
  • Animals
  • Catalytic Domain (genetics)
  • Cell Transformation, Neoplastic (genetics)
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Enzymologic (genetics)
  • MAP Kinase Kinase 1
  • MAP Kinase Signaling System (genetics)
  • Mice
  • Mitogen-Activated Protein Kinase Kinases (genetics, metabolism)
  • Mitogen-Activated Protein Kinases (genetics)
  • Models, Molecular
  • Molecular Conformation
  • Mutation (genetics)
  • NIH 3T3 Cells
  • Neoplasms (enzymology, genetics)
  • Oncogenes (genetics)
  • Oocytes
  • Phosphorylation
  • Phosphotransferases (genetics, metabolism)
  • Proto-Oncogene Proteins B-raf
  • Proto-Oncogene Proteins c-raf (antagonists & inhibitors, genetics, metabolism)
  • Up-Regulation (genetics)
  • Xenopus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: